Literature DB >> 19781632

Mathematical modelling of interferon-gamma signalling in pancreatic stellate cells reflects and predicts the dynamics of STAT1 pathway activity.

Katja Rateitschak1, Anna Karger, Brit Fitzner, Falko Lange, Olaf Wolkenhauer, Robert Jaster.   

Abstract

Signal transducer and activator of transcription (STAT) 1 is essentially involved in the mediation of antifibrotic interferon-gamma (IFN gamma) effects in pancreatic stellate cells (PSC). Here, we have further analysed the activation of the STAT1 pathway in a PSC line by combining quantitative data generation with mathematical modelling. At saturating concentrations of IFN gamma, a triphasic pattern of STAT1 activation was observed. An initial, rapid induction of phospho-STAT1 was followed by a plateau phase and another, long-lasting phase of further increase. The late increase occurred despite enhanced expression of the feedback inhibitor (SOCS1), and corresponded to increased levels of total STAT1 protein. If IFN gamma was applied at non-saturating concentrations, phospho-STAT1 and SOCS1 levels peaked and declined again over a 12 hour period, while STAT1 protein levels remained high. The mathematical model, based on a system of ordinary differential equations, describes temporal changes of the network components as a function of interactions and transport processes. The model reproduced activation profiles of all components of the STAT1 pathway that were experimentally analysed. Furthermore, it successfully predicted the dynamics of network components in additional experimental studies. Based on experimental findings and the results obtained from modelling, we suggest exhaustion of applied IFN gamma and STAT1 dephosphorylation by tyrosine phosphatases as limiting factors of STAT1 activation in PSC. In contrast, we did not obtain compelling evidence that SOCS1 acts as an efficient feedback inhibitor in our experimental system. We believe that further investigations into mathematical modelling of the STAT1 pathway will improve the understanding of the antifibrotic interferon action.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19781632     DOI: 10.1016/j.cellsig.2009.09.019

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  15 in total

1.  Macrophage polarization drives granuloma outcome during Mycobacterium tuberculosis infection.

Authors:  Simeone Marino; Nicholas A Cilfone; Joshua T Mattila; Jennifer J Linderman; JoAnne L Flynn; Denise E Kirschner
Journal:  Infect Immun       Date:  2014-11-03       Impact factor: 3.441

2.  The competitive nature of signal transducer and activator of transcription complex formation drives phenotype switching of T cells.

Authors:  Ildar I Sadreev; Michael Z Q Chen; Yoshinori Umezawa; Vadim N Biktashev; Claudia Kemper; Diana V Salakhieva; Gavin I Welsh; Nikolay V Kotov
Journal:  Immunology       Date:  2017-11-22       Impact factor: 7.397

3.  Molecular determinants of the antitumor effects of trichostatin A in pancreatic cancer cells.

Authors:  Elisabeth Emonds; Brit Fitzner; Robert Jaster
Journal:  World J Gastroenterol       Date:  2010-04-28       Impact factor: 5.742

4.  Distinct antifibrogenic effects of erlotinib, sunitinib and sorafenib on rat pancreatic stellate cells.

Authors:  Anne Elsner; Falko Lange; Brit Fitzner; Martin Heuschkel; Bernd Joachim Krause; Robert Jaster
Journal:  World J Gastroenterol       Date:  2014-06-28       Impact factor: 5.742

5.  Insights into erlotinib action in pancreatic cancer cells using a combined experimental and mathematical approach.

Authors:  Falko Lange; Katja Rateitschak; Christina Kossow; Olaf Wolkenhauer; Robert Jaster
Journal:  World J Gastroenterol       Date:  2012-11-21       Impact factor: 5.742

6.  Promoter occupancy of STAT1 in interferon responses is regulated by processive transcription.

Authors:  Ivana Wiesauer; Clemens Gaumannmüller; Iris Steinparzer; Birgit Strobl; Pavel Kovarik
Journal:  Mol Cell Biol       Date:  2014-12-15       Impact factor: 4.272

7.  Studies on mechanisms of interferon-gamma action in pancreatic cancer using a data-driven and model-based approach.

Authors:  Falko Lange; Katja Rateitschak; Brit Fitzner; Ralf Pöhland; Olaf Wolkenhauer; Robert Jaster
Journal:  Mol Cancer       Date:  2011-02-10       Impact factor: 27.401

8.  Parameter identifiability and sensitivity analysis predict targets for enhancement of STAT1 activity in pancreatic cancer and stellate cells.

Authors:  Katja Rateitschak; Felix Winter; Falko Lange; Robert Jaster; Olaf Wolkenhauer
Journal:  PLoS Comput Biol       Date:  2012-12-20       Impact factor: 4.475

Review 9.  Computational models of the JAK1/2-STAT1 signaling.

Authors:  Anna Gambin; Agata Charzyńska; Aleksandra Ellert-Miklaszewska; Mikołaj Rybiński
Journal:  JAKSTAT       Date:  2013-04-15

Review 10.  Molecular mechanisms of pancreatic myofibroblast activation in chronic pancreatitis and pancreatic ductal adenocarcinoma.

Authors:  Andrew Cannon; Christopher Michael Thompson; Rakesh Bhatia; Katharine Anne Armstrong; Joyce Christopher Solheim; Sushil Kumar; Surinder Kumar Batra
Journal:  J Gastroenterol       Date:  2021-07-19       Impact factor: 6.772

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.